MINI FUTURE LONG - IPSEN | Real-time Euronext Paris 13:29:38 03/06/2024 BST | ||
| 1.75 EUR | -0.57% |
|
| 1 month | +24.38% | ||
| 3 months | +108.28% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
Latest news about IPSEN
| Date | Price | Change |
|---|---|---|
| 03/06/24 | 1.75 | -0.57% |
| 31/05/24 | 1.76 | +3.83% |
| 30/05/24 | 1.695 | +1.19% |
| 29/05/24 | 1.675 | +1.82% |
| 28/05/24 | 1.645 | -6.00% |
Real-time Euronext Paris
Last update June 03, 2024 at 01:29 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
BNP Paribas
|
| V5WHB | |
| ISIN | FRBNPP04ETE7 |
| Date issued | 21/06/2022 |
| Strike | 86.3 € |
| Maturity | Unlimited |
| Parity | 20 : 1 |
| Emission price | 0.26 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.445 € |
|---|---|
| Lowest since issue | 0.285 € |
| Spread | 0.01 € |
| Spread % | 0.57% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
120.6
EUR
Average target price
126.4
EUR
Spread / Average Target
+4.81%
- Stock Market
- Certificates
- V5WHB Certificat
